Salvador Borrós Gómez, PhD
Director of IQS - Head of GEMAT Group - Professor
+34932672000
RESEARCH LINES
APPLICATION OF MATERIAL SCIENCE TO BIOMATERIAL HERITAGE CONSERVATION:
- Stimuli-responsive polymeric nanoparticles for controlled drug release.
- Design of biomimetic surfaces with chemical and mechanical cell signalling. Smart surfaces.
- Design and manufacture of scaffolds for bone and cartilage tissue regeneration.
POLYMERIC MATERIALS WITH INDUSTRIAL APPLICATIONS:
- Design of high performance adhesives.
- Study of the chemistry of vulcanisation.
- Design of composites with controlled viscoelasticity.
- Surface modification of fillers by cold plasma.
FUNCTIONAL MATERIALS:
- New methods for obtaining polymer thin films (iCVD).
- Polymers with high proton conductivity for fuel cell membranes.
- Material for Rapid Manufacturing.
COORDINATOR:
School of Engineering
Materials Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.
LATEST PROJECTS
ZwiRNA (Nanopartículas zwiteriónicas como vacunas de ARNm contra el cáncer pulmonar)
Desarrollo de Nanopartículas zwiteriónicas de Poli(beta-aminoester) como vacunas de mRNA para tratar el cáncer de pulmón de células no pequeñas (zwiRNA).
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LIVENANO (Nuevas nanoterapias industrialmente escalables para tratar la hipertensión portal y la fibrosis hepática en humanos)
Producción a nivel GMP de polímeros terapéuticos y nanopartículas a nivel pre-clínico para tratar patologías hepáticas
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
Biomod (Modelos biomecánicos avanzados para la práctica quirúrgica maxilofacial labiopalatina)
Desarrollo de modelos biomecánicos avanzados para planificación y mejora de la practica quirúrgica para cirugía maxilofacial labiopalatina.
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Industrial Products Engineering Group (GEPI)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LINKED NEWS
Doctoral thesis
Restoration of Cultural Heritage Objects Affected by Corrosion
11/12/2023
Dr Patricia Giménez recently defended her doctoral thesis at IQS, in which she established a new methodology for conserving and restoring ductile metals of cultural heritage objects based on the use of cold plasma.
READ FULL NEW
Research
Improving Duchenne Muscular Dystrophy Therapies
18/09/2023
The GEMAT group is working in collaboration with the Duchenne Parent Project Spain association to develop viral vector coating biomaterials to improve gene therapy for the treatment of Duchenne muscular dystrophy.
READ FULL NEW
Doctoral thesis
Polymers for Invisible Nanoparticles in mRNA Vaccines
13/09/2023
Dr Coral García recently defended her doctoral thesis at IQS, in which she managed to develop a system of polymeric vaccines based on mRNA that are invisible to premature elimination by the immune system and ensure that they exclusively impact target cells.
READ FULL NEW
Research
Advanced Biomechanical Models for Paediatric Maxillofacial Surgery
06/02/2023
Led by IQS researchers, the BIOMOD project aims to develop new advanced biomechanical models through 3D techniques to improve surgical practice and the implants used in paediatric maxillofacial surgery.
READ FULL NEW
Research
Invisible, Targeted mRNA Vaccines
03/11/2022
The GEMAT group at IQS is working on the zwiRNA project with the goal of designing a new state-of-the-art therapeutic vaccine for the treatment of lung cancer.
READ FULL NEW
Doctoral thesis
Hydrogel Dressings for Diabetic Foot Ulcer Treatment
02/09/2022
Dr José Antonio Durán defended his doctoral thesis at IQS, in which he developed dressings with hydrogels as platforms for the controlled release of miRNAs for diabetic foot ulcer treatment.
READ FULL NEW
Doctoral thesis
A Bioabsorbable Patch to Treat Aortic Dissection
16/05/2022
In her doctoral thesis conducted at IQS, Dr Noemí Balà has designed a specific device to treat aortic dissection featuring mechanical properties similar to those of the artery, making it possible to improve current treatments.
READ FULL NEW
Research
Obtaining an artificial placenta, a highly disruptive project
16/03/2022
IQS is participating alongside other technological and medical research centers in Barcelona on a highly advanced and pioneering project in Europe to produce and use an artificial placenta to ensure survival for extremely premature newborns.
READ FULL NEW
Doctoral thesis
Optimization of the Silicone Hydrosilylation Process with Platinum Catalysts
20/01/2022
Dr. Anna del Pino recently defended her doctoral thesis at IQS, on the optimisation of the manufacturing process of sanitary quality silicone tubes. The research has been carried out within the Industrial Doctorate Plan, in collaboration with the company Venair.
READ FULL NEW
Research
Development of a new endovascular medical device
26/10/2021
Within the Collaboration Challenges program, Aortyx and the GEMAT group collaborate in the development and preclinical validation of a new endovascular medical device with localized and controlled release of anti-progression drugs for aneurysms.
READ FULL NEW
Research
Activatable Antibodies to Increase Selectivity for Brain Tumour Therapies
19/10/2021
In the Materials Engineering Group (GEMAT) at the IQS School of Engineering, the team led by Dr Benjami Oller Salvia is working to take on two of the great challenges with GBM therapies.
READ FULL NEW
Doctoral thesis
Bacteriophobic Nanostructured Surfaces
29/07/2021
Dr Cristina García has recently defended her doctoral thesis at IQS, in which she has developed a urinary catheter equipped with a micro-and nano-structured coating with bacteriophobic characteristics, offering a clear alternative to commercial catheters.
READ FULL NEW
Doctoral thesis
Materiales zwitteriónicos para aplicaciones biomédicas
03/06/2021
El Dr. Pol Cabanach ha defendido recientemente su tesis doctoral en IQS, en la que desarrolla dos tecnologías basadas en materiales zwitteriónicos: un sistema oral de liberación de fármacos para el tratamiento de la malaria y una fotorresistencia para la microimpresión de micro-robots no-inmunogénicos.
READ FULL NEW
Doctoral thesis
Nuevo sistema de sellado para cirugía fetal
03/06/2021
El Dr. Germán Febas defendió recientemente su tesis doctoral realizada en el grupo GEMAT de IQS, donde ha desarrollado y patentado un dispositivo médico que sella el orificio realizado en la membrana corioamniótica después de una fetoscopia, con el objetivo final de reducir el riesgo de rotura de esta membrana y salvar la vida del futuro bebé.
READ FULL NEW
Research
Tracheal stent: example of 3D printing applied to the healthcare industry (QuirofAM)
04/04/2021
Within the framework of the QuirofAM project, the CIM center, the IQS GEMAT group and the Tractivus spin-off, have co-developed a 3D printer that allows printing of medical grade silicone for the manufacture of medical devices. As a first demonstrator, the researchers have developed a completely customized tracheal stent.
READ FULL NEW
News
Confocal Microscopy
05/02/2021
IQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.
READ FULL NEW
Research
Adhesive patch for arterial repairs
05/02/2021
IQS researchers of the Endovascular Repair Patch project, carried out within the AGAUR 'Product' call, have achieved both the definitive design of the deployer and the biocompatible materials that allow the administration of a patch for the repair of arteries affected by aortic dissection .
READ FULL NEW
Interview
Dr Borrós and Dr Fornaguera, leaders of the CoviNanoVax project
08/01/2021
“We have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4ºC, and obtained through an easily scalable process.“
READ FULL NEW
